News in the Life Sciences Industry

AUSTIN, Texas, July 29, 2020 /PRNewswire/ -- Direct Biologics, LLC, is announcing today that it has received approval from FDA that it may proceed with a Phase II trial under an Investigational New Drug (IND) application for the use of ExoFlo(TM), a bone marrow-derived extracellular vesicle and... Read more ››

SAN DIEGO, July 29, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its second quarter... Read more ››

LEE'S SUMMIT, Mo., July 29, 2020 /PRNewswire/ -- Eurofins U.S. Clinical Diagnostics announced the launch date of... Read more ››

SAN DIEGO, July 29, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2020 on Monday, August 10 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On... Read more ››

RADNOR, Pa., July 29, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the second quarter ended... Read more ››

SAN DIEGO, July 29, 2020 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the second quarter and six months... Read more ››

STRASBOURG, France and PHILADELPHIA, July 29, 2020 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced today that the company is presenting at several virtual investor conferences during August... Read more ››

TEMPE, Ariz., July 29, 2020 /PRNewswire/ -- Benchmark Electronics, Inc. (NYSE: BHE) today announced financial results for the second quarter ended June 30, 2020.

SECAUCUS, N.J., July 29, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process of extracting viral RNA from specimens* and... Read more ››

ROCKVILLE, Md., July 29, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage... Read more ››

ARLINGTON, Va., July 29, 2020 /PRNewswire/ -- Alarming new data... Read more ››